Cargando…

Lymphoma Developing in a Patient With Long-term Antitumor Necrosis Factor Therapy

Detalles Bibliográficos
Autores principales:	Fensterseifer, Giovana Serrão, Carvalho, André, Boff, Ana Letícia, Schwartz, Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464557/ https://www.ncbi.nlm.nih.gov/pubmed/36159104 http://dx.doi.org/10.5826/dpc.1203a132

Ejemplares similares

Entodermoscopy in the Diagnosis of Tinea Nigra: Two Case Reports
por: Lima Dantas, Manuela, et al.
Publicado: (2020)

Mouth breathing in children with learning disorders
por: Fensterseifer, Giovana Serrão, et al.
Publicado: (2015)

Development and validation of printed educational material for isotretinoin users()()
por: Dexheimer, Letícia Santos, et al.
Publicado: (2021)

The Long-Term Clinical Effectiveness of Ustekinumab in Antitumor Necrosis Factor-Experienced Crohn’s Disease Patients
por: Altuwaijri, Mansour, et al.
Publicado: (2022)

Long‐term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease
por: Shiga, Hisashi, et al.
Publicado: (2022)

Leveling the playing field in long-term care
por: Wohlgemut, Joel
Publicado: (2022)

Proliferating trichilemmal tumor()
por: Pereira, Andrea Abê, et al.
Publicado: (2023)

Adherence to Long-term Warfarin Therapy Remains Challenging
por: Ward, Melea
Publicado: (2013)

Q Fever Risk in Patients Treated with Chronic Antitumor Necrosis Factor-Alpha Therapy
por: Hirsch, Julianna, et al.
Publicado: (2016)

Post-traumatic chronic seronegative monarthritis responding to antitumor necrosis factor-alpha therapy
por: Fairweather, Jamie, et al.
Publicado: (2018)

Antitumor effects of THC.
por: Huff, J, et al.
Publicado: (2000)

Current and new antitumor necrosis factor agents in perspective
por: Maini, Ravinder N
Publicado: (2004)

A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK(+) lymphomas
por: Rindone, Giovanni, et al.
Publicado: (2022)

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
por: Loo, Kimberly, et al.
Publicado: (2022)

Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up
por: Dreyling, Martin, et al.
Publicado: (2022)

Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma
por: Santos, Juliana Carvalho, et al.
Publicado: (2022)

Long‐term outcomes of relapsed/refractory double‐hit lymphoma (r/r DHL) treated with CD19/22 CAR T‐cell cocktail therapy
por: Wei, Jia, et al.
Publicado: (2020)

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014)

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
por: Al Sulais, Eman, et al.
Publicado: (2020)

Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma
por: Che, Yuxuan, et al.
Publicado: (2023)

Long-Term Outcomes Following Myocardial Infarction in Young Adult Survivors of Hodgkin Lymphoma: The YOUNG-MI Registry
por: Divakaran, Sanjay, et al.
Publicado: (2021)

Epipericardial fat necrosis: an unusual cause of chest pain
por: Giassi, Karina de Souza, et al.
Publicado: (2013)

From Bone Marrow Necrosis to Gaucher Disease; A Long Way to Run
por: Erdem, Neslihan, et al.
Publicado: (2015)

Long-term follow up of Hodgkin lymphoma
por: Perez-Callejo, David, et al.
Publicado: (2018)

Peer-assisted learning: a platform for long-term development for both tutors and tutees
por: Jamshaid, Shiraz, et al.
Publicado: (2016)

Response to letter to the Editors—Safety of long-term denosumab therapy
por: Stopeck, Alison T., et al.
Publicado: (2016)

Sub dural hematoma due to long term carbamazepine therapy
por: Kannaujia, Ashish, et al.
Publicado: (2016)

Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis
por: Kurz, Katharina, et al.
Publicado: (2015)

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton’s tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)
por: Rule, Simon A., et al.
Publicado: (2019)

Cutaneous T-Cell Lymphoma with Nasal Necrosis
por: Shaum, Katherine, et al.
Publicado: (2015)

Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
por: Zent, Clive S., et al.
Publicado: (2020)

The Long Journey of Cardiac Lymphoma Follow-up
por: Lee, Joseph C., et al.
Publicado: (2020)

Antitumor necrosis factor-α antibodies as a noveltherapy for hepatocellular carcinoma
por: Li, Wei, et al.
Publicado: (2018)

Lysosome Labilizers Potentiate the Antitumor Effects of Tumor Necrosis Factor‐α
por: Masegi, Tsukio, et al.
Publicado: (1993)

CHRONIC ALLOGENEIC DISEASE : II. DEVELOPMENT OF LYMPHOMAS
por: Armstrong, Martine Y. K., et al.
Publicado: (1970)

Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma
por: Vaios, Eugene J., et al.
Publicado: (2022)

Gastroprotection during long-term dual antiplatelet therapy: to give or not to give?
por: Sbrana, Francesco, et al.
Publicado: (2021)

Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
por: Vuyyuru, Sudheer K, et al.
Publicado: (2021)

Risk of Orthopedic Surgical Site Infections in Patients with Rheumatoid Arthritis Treated with Antitumor Necrosis Factor Alfa Therapy
por: da Cunha, Bernardo Matos, et al.
Publicado: (2012)

Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy
por: Mizoshita, Tsutomu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q9r7j7mi7ej1gv1uoq3du44s1g